ID   HMCS1_HUMAN             Reviewed;         520 AA.
AC   Q01581; B2RDL8;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=Hydroxymethylglutaryl-CoA synthase, cytoplasmic;
DE            Short=HMG-CoA synthase;
DE            EC=2.3.3.10;
DE   AltName: Full=3-hydroxy-3-methylglutaryl coenzyme A synthase;
GN   Name=HMGCS1; Synonyms=HMGCS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fibroblast;
RX   PubMed=1358203; DOI=10.1016/0167-4781(92)90172-V;
RA   Russ A.P., Ruzicka V., Maerz W., Appelhans H., Gross W.;
RT   "Amplification and direct sequencing of a cDNA encoding human
RT   cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase.";
RL   Biochim. Biophys. Acta 1132:329-331(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND MUTAGENESIS.
RC   TISSUE=Fetal adrenal gland;
RX   PubMed=7913309; DOI=10.1006/abbi.1994.1273;
RA   Rokosz L.L., Boulton D.A., Butkiewicz E.A., Sanyal G., Cueto M.A.,
RA   Lachance P.A., Hermes J.D.;
RT   "Human cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme A synthase:
RT   expression, purification, and characterization of recombinant wild-
RT   type and Cys129 mutant enzymes.";
RL   Arch. Biochem. Biophys. 312:1-13(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-476 AND SER-495, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-46 AND LYS-273, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 AND SER-495, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-495 AND SER-516,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: This enzyme condenses acetyl-CoA with acetoacetyl-CoA to
CC       form HMG-CoA, which is the substrate for HMG-CoA reductase.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + H(2)O + acetoacetyl-CoA = (S)-3-
CC       hydroxy-3-methylglutaryl-CoA + CoA. {ECO:0000255|PROSITE-
CC       ProRule:PRU10116}.
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; (R)-mevalonate
CC       biosynthesis; (R)-mevalonate from acetyl-CoA: step 2/3.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the HMG-CoA synthase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH00297.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66435; CAA47061.1; -; mRNA.
DR   EMBL; L25798; AAA62411.1; -; mRNA.
DR   EMBL; BT007302; AAP35966.1; -; mRNA.
DR   EMBL; AK315593; BAG37965.1; -; mRNA.
DR   EMBL; CH471119; EAW56054.1; -; Genomic_DNA.
DR   EMBL; BC000297; AAH00297.2; ALT_INIT; mRNA.
DR   CCDS; CCDS34154.1; -.
DR   PIR; S27197; S27197.
DR   PIR; S45497; S45497.
DR   RefSeq; NP_001091742.1; NM_001098272.2.
DR   RefSeq; NP_001311148.1; NM_001324219.1.
DR   RefSeq; NP_001311149.1; NM_001324220.1.
DR   RefSeq; NP_001311151.1; NM_001324222.1.
DR   RefSeq; NP_001311152.1; NM_001324223.1.
DR   RefSeq; NP_001311153.1; NM_001324224.1.
DR   RefSeq; NP_001317592.1; NM_001330663.1.
DR   RefSeq; NP_002121.4; NM_002130.7.
DR   UniGene; Hs.397729; -.
DR   UniGene; Hs.741287; -.
DR   PDB; 2P8U; X-ray; 2.00 A; A/B=16-470.
DR   PDBsum; 2P8U; -.
DR   ProteinModelPortal; Q01581; -.
DR   SMR; Q01581; -.
DR   BioGrid; 109400; 31.
DR   IntAct; Q01581; 2.
DR   STRING; 9606.ENSP00000322706; -.
DR   GuidetoPHARMACOLOGY; 638; -.
DR   SwissLipids; SLP:000000724; -.
DR   iPTMnet; Q01581; -.
DR   PhosphoSitePlus; Q01581; -.
DR   SwissPalm; Q01581; -.
DR   BioMuta; HMGCS1; -.
DR   DMDM; 1708239; -.
DR   EPD; Q01581; -.
DR   MaxQB; Q01581; -.
DR   PaxDb; Q01581; -.
DR   PeptideAtlas; Q01581; -.
DR   PRIDE; Q01581; -.
DR   DNASU; 3157; -.
DR   Ensembl; ENST00000325110; ENSP00000322706; ENSG00000112972.
DR   Ensembl; ENST00000433297; ENSP00000399402; ENSG00000112972.
DR   GeneID; 3157; -.
DR   KEGG; hsa:3157; -.
DR   UCSC; uc003jnq.6; human.
DR   CTD; 3157; -.
DR   DisGeNET; 3157; -.
DR   GeneCards; HMGCS1; -.
DR   HGNC; HGNC:5007; HMGCS1.
DR   HPA; CAB032907; -.
DR   HPA; HPA036913; -.
DR   HPA; HPA036914; -.
DR   MIM; 142940; gene.
DR   neXtProt; NX_Q01581; -.
DR   OpenTargets; ENSG00000112972; -.
DR   PharmGKB; PA29337; -.
DR   eggNOG; KOG1393; Eukaryota.
DR   eggNOG; COG3425; LUCA.
DR   GeneTree; ENSGT00390000006096; -.
DR   HOGENOM; HOG000012351; -.
DR   HOVERGEN; HBG051912; -.
DR   InParanoid; Q01581; -.
DR   KO; K01641; -.
DR   OMA; QRCISEE; -.
DR   OrthoDB; EOG091G0791; -.
DR   PhylomeDB; Q01581; -.
DR   TreeFam; TF105361; -.
DR   BioCyc; MetaCyc:ENSG00000112972-MONOMER; -.
DR   BRENDA; 2.3.3.10; 2681.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   UniPathway; UPA00058; UER00102.
DR   ChiTaRS; HMGCS1; human.
DR   EvolutionaryTrace; Q01581; -.
DR   GenomeRNAi; 3157; -.
DR   PRO; PR:Q01581; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000112972; -.
DR   CleanEx; HS_HMGCS1; -.
DR   ExpressionAtlas; Q01581; baseline and differential.
DR   Genevisible; Q01581; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0004421; F:hydroxymethylglutaryl-CoA synthase activity; TAS:Reactome.
DR   GO; GO:0016853; F:isomerase activity; IEA:Ensembl.
DR   GO; GO:0043177; F:organic acid binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0071397; P:cellular response to cholesterol; IEA:Ensembl.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IEA:InterPro.
DR   GO; GO:0006629; P:lipid metabolic process; NAS:ProtInc.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0055094; P:response to lipoprotein particle; IEA:Ensembl.
DR   GO; GO:0009645; P:response to low light intensity stimulus; IEA:Ensembl.
DR   GO; GO:0014074; P:response to purine-containing compound; IEA:Ensembl.
DR   GO; GO:0046690; P:response to tellurium ion; IEA:Ensembl.
DR   GO; GO:0033197; P:response to vitamin E; IEA:Ensembl.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR000590; HMG_CoA_synt_AS.
DR   InterPro; IPR013746; HMG_CoA_synt_C_dom.
DR   InterPro; IPR013528; HMG_CoA_synth_N.
DR   InterPro; IPR010122; HMG_CoA_synthase_euk.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF08540; HMG_CoA_synt_C; 1.
DR   Pfam; PF01154; HMG_CoA_synt_N; 1.
DR   SUPFAM; SSF53901; SSF53901; 3.
DR   TIGRFAMs; TIGR01833; HMG-CoA-S_euk; 1.
DR   PROSITE; PS01226; HMG_COA_SYNTHASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cholesterol biosynthesis;
KW   Cholesterol metabolism; Complete proteome; Cytoplasm;
KW   Lipid biosynthesis; Lipid metabolism; Phosphoprotein;
KW   Reference proteome; Steroid biosynthesis; Steroid metabolism;
KW   Sterol biosynthesis; Sterol metabolism; Transferase.
FT   CHAIN         1    520       Hydroxymethylglutaryl-CoA synthase,
FT                                cytoplasmic.
FT                                /FTId=PRO_0000213747.
FT   ACT_SITE     95     95       Proton donor/acceptor.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10116}.
FT   ACT_SITE    129    129       Acyl-thioester intermediate.
FT   ACT_SITE    264    264       Proton donor/acceptor.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10116}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      46     46       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     273    273       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     476    476       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     495    495       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     516    516       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MUTAGEN     129    129       C->A,S: Loss of activity.
FT                                {ECO:0000269|PubMed:7913309}.
FT   CONFLICT    248    248       G -> A (in Ref. 1; CAA47061).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       K -> N (in Ref. 1; CAA47061).
FT                                {ECO:0000305}.
FT   CONFLICT    299    299       E -> K (in Ref. 1; CAA47061).
FT                                {ECO:0000305}.
FT   CONFLICT    364    364       Q -> H (in Ref. 1; CAA47061).
FT                                {ECO:0000305}.
FT   CONFLICT    420    420       P -> Q (in Ref. 1; CAA47061).
FT                                {ECO:0000305}.
FT   CONFLICT    519    520       EH -> VW (in Ref. 1; CAA47061).
FT                                {ECO:0000305}.
FT   STRAND       18     25       {ECO:0000244|PDB:2P8U}.
FT   STRAND       28     32       {ECO:0000244|PDB:2P8U}.
FT   HELIX        33     40       {ECO:0000244|PDB:2P8U}.
FT   HELIX        46     51       {ECO:0000244|PDB:2P8U}.
FT   STRAND       55     57       {ECO:0000244|PDB:2P8U}.
FT   HELIX        65     79       {ECO:0000244|PDB:2P8U}.
FT   HELIX        84     86       {ECO:0000244|PDB:2P8U}.
FT   STRAND       87     93       {ECO:0000244|PDB:2P8U}.
FT   STRAND      100    102       {ECO:0000244|PDB:2P8U}.
FT   HELIX       104    108       {ECO:0000244|PDB:2P8U}.
FT   HELIX       109    111       {ECO:0000244|PDB:2P8U}.
FT   TURN        112    116       {ECO:0000244|PDB:2P8U}.
FT   STRAND      124    127       {ECO:0000244|PDB:2P8U}.
FT   HELIX       128    130       {ECO:0000244|PDB:2P8U}.
FT   HELIX       131    143       {ECO:0000244|PDB:2P8U}.
FT   STRAND      152    161       {ECO:0000244|PDB:2P8U}.
FT   HELIX       169    171       {ECO:0000244|PDB:2P8U}.
FT   STRAND      173    184       {ECO:0000244|PDB:2P8U}.
FT   STRAND      186    189       {ECO:0000244|PDB:2P8U}.
FT   STRAND      195    198       {ECO:0000244|PDB:2P8U}.
FT   STRAND      203    205       {ECO:0000244|PDB:2P8U}.
FT   HELIX       218    247       {ECO:0000244|PDB:2P8U}.
FT   HELIX       255    257       {ECO:0000244|PDB:2P8U}.
FT   STRAND      259    263       {ECO:0000244|PDB:2P8U}.
FT   HELIX       268    285       {ECO:0000244|PDB:2P8U}.
FT   HELIX       289    291       {ECO:0000244|PDB:2P8U}.
FT   HELIX       293    295       {ECO:0000244|PDB:2P8U}.
FT   HELIX       299    301       {ECO:0000244|PDB:2P8U}.
FT   HELIX       306    308       {ECO:0000244|PDB:2P8U}.
FT   HELIX       313    322       {ECO:0000244|PDB:2P8U}.
FT   HELIX       324    330       {ECO:0000244|PDB:2P8U}.
FT   HELIX       333    335       {ECO:0000244|PDB:2P8U}.
FT   HELIX       336    341       {ECO:0000244|PDB:2P8U}.
FT   HELIX       345    347       {ECO:0000244|PDB:2P8U}.
FT   HELIX       348    359       {ECO:0000244|PDB:2P8U}.
FT   HELIX       362    365       {ECO:0000244|PDB:2P8U}.
FT   STRAND      369    376       {ECO:0000244|PDB:2P8U}.
FT   TURN        377    379       {ECO:0000244|PDB:2P8U}.
FT   STRAND      380    388       {ECO:0000244|PDB:2P8U}.
FT   HELIX       397    403       {ECO:0000244|PDB:2P8U}.
FT   TURN        404    407       {ECO:0000244|PDB:2P8U}.
FT   HELIX       408    413       {ECO:0000244|PDB:2P8U}.
FT   STRAND      415    417       {ECO:0000244|PDB:2P8U}.
FT   HELIX       420    433       {ECO:0000244|PDB:2P8U}.
FT   STRAND      453    458       {ECO:0000244|PDB:2P8U}.
FT   STRAND      464    468       {ECO:0000244|PDB:2P8U}.
SQ   SEQUENCE   520 AA;  57294 MW;  C669212BF86CFF9B CRC64;
     MPGSLPLNAE ACWPKDVGIV ALEIYFPSQY VDQAELEKYD GVDAGKYTIG LGQAKMGFCT
     DREDINSLCM TVVQNLMERN NLSYDCIGRL EVGTETIIDK SKSVKTNLMQ LFEESGNTDI
     EGIDTTNACY GGTAAVFNAV NWIESSSWDG RYALVVAGDI AVYATGNARP TGGVGAVALL
     IGPNAPLIFE RGLRGTHMQH AYDFYKPDML SEYPIVDGKL SIQCYLSALD RCYSVYCKKI
     HAQWQKEGND KDFTLNDFGF MIFHSPYCKL VQKSLARMLL NDFLNDQNRD KNSIYSGLEA
     FGDVKLEDTY FDRDVEKAFM KASSELFSQK TKASLLVSNQ NGNMYTSSVY GSLASVLAQY
     SPQQLAGKRI GVFSYGSGLA ATLYSLKVTQ DATPGSALDK ITASLCDLKS RLDSRTGVAP
     DVFAENMKLR EDTHHLVNYI PQGSIDSLFE GTWYLVRVDE KHRRTYARRP TPNDDTLDEG
     VGLVHSNIAT EHIPSPAKKV PRLPATAAEP EAAVISNGEH
//
